1 |
(-)-3-(4-aminophenyl)-2-methoxypropionic acid |
- |
- |
- |
- |
097 1件: 97 💬 |
2 |
(r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid |
Butyric Acid |
1件: D05866 D05866 💬 |
- |
- |
097 1件: 97 💬 |
3 |
(s)-(-)-3-(4-aminophenyl)-2-methoxypropionic acid |
- |
- |
- |
- |
097 1件: 97 💬 |
4 |
(s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxyben |
- |
- |
- |
- |
097 1件: 97 💬 |
5 |
(s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride |
- |
- |
- |
- |
097 1件: 97 💬 |
6 |
-aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 2件: 96, 97 💬 |
7 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
8 |
0.25mg rpc103 |
- |
- |
- |
- |
097 1件: 97 💬 |
9 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
10 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
11 |
1 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
12 |
1.0 mg rpc103 |
- |
- |
- |
- |
097 1件: 97 💬 |
13 |
1.0 mg rpc1063 |
- |
- |
- |
- |
097 1件: 97 💬 |
14 |
1.remicade |
- |
- |
- |
- |
097 1件: 97 💬 |
15 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
16 |
100 |
- |
- |
- |
- |
006 2件: 6 , 97 💬 |
17 |
100 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
18 |
150 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
19 |
1500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
20 |
15n2-tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97 💬 |
21 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
22 |
2'-fucosyllactose |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
23 |
2-hydroxybenzoic acid |
Salicylic acid |
1件: D00097 D00097 💬 |
- |
- |
097 1件: 97 💬 |
24 |
20 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
25 |
225mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 1件: 97 💬 |
26 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
27 |
25 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
28 |
250mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
29 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
2件: D00018 D00018, D03370 D03370 💬 |
- |
- |
097 1件: 97 💬 |
30 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
1件: D00396 D00396 💬 |
- |
- |
096 2件: 96, 97 💬 |
31 |
331731-18-1 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
32 |
40 mg msb11022 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
33 |
42942019 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
34 |
450 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
35 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 1件: 97 💬 |
36 |
5-amino salicylic acid |
Salicylic acid |
1件: D00097 D00097 💬 |
- |
- |
097 1件: 97 💬 |
37 |
5-amino salicylic acid (5-asa) |
Mesalazine |
2件: D00097 D00097, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
38 |
5-amino-2-hydroxybenzoic acid |
Salicylic acid |
1件: D00097 D00097 💬 |
- |
- |
097 1件: 97 💬 |
39 |
5-aminosalicyclic acid |
- |
- |
- |
- |
097 1件: 97 💬 |
40 |
5-aminosalicylate (pentasa, ferring) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
41 |
5-aminosalicylic acid |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
42 |
5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
43 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
3件: D00162 D00162, D00377 D00377, D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
44 |
5-asa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
45 |
5-asa (5-aminosalicylate) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
46 |
5-asa mmx |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
47 |
5-htp |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
48 |
50 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
49 |
500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
50 |
549-0261/f02-01 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
51 |
6 mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
52 |
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid |
- |
- |
- |
- |
097 1件: 97 💬 |
53 |
6-mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 3件: 96, 97, 164 💬 |
54 |
6-mp |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
55 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
56 |
750mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
57 |
75mg shp647 (pf-00547659) |
- |
- |
- |
- |
097 1件: 97 💬 |
58 |
90 mg hydrocortisone acetate suppository with sephure suppository applicator |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
59 |
[124i]ib pf 06687234 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
60 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
61 |
[18f]fspg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
62 |
[bi 655130] |
- |
- |
- |
- |
097 1件: 97 💬 |
63 |
[cc-10004] |
- |
- |
- |
- |
097 1件: 97 💬 |
64 |
[n/a] |
- |
- |
- |
- |
097 2件: 97, 299 💬 |
65 |
A multistrain probiotic product (dsf) |
- |
- |
- |
- |
097 1件: 97 💬 |
66 |
A07da03 |
- |
- |
- |
- |
097 1件: 97 💬 |
67 |
A: 1 dosis |
- |
- |
- |
- |
097 1件: 97 💬 |
68 |
Ab (antibiotics) |
- |
- |
- |
- |
097 1件: 97 💬 |
69 |
Abalimumab |
- |
- |
- |
- |
097 1件: 97 💬 |
70 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
71 |
Abatacept (aba) |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
097 1件: 97 💬 |
72 |
Abbv-006 |
- |
- |
- |
- |
097 1件: 97 💬 |
73 |
Abbv-066 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
74 |
Abbv-323 |
- |
- |
- |
- |
053 2件: 53, 97 💬 |
75 |
Abbv-323 dose a |
- |
- |
- |
- |
097 1件: 97 💬 |
76 |
Abbv-323 dose b |
- |
- |
- |
- |
097 1件: 97 💬 |
77 |
Abgn-168h |
- |
- |
- |
- |
097 1件: 97 💬 |
78 |
Abi-m201 |
- |
- |
- |
- |
097 1件: 97 💬 |
79 |
Abrilumab |
Abrilumab |
1件: D10540 D10540 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
80 |
Abt-494 |
- |
- |
- |
- |
041 6件: 41, 46, 49, 96, 97, 271 💬 |
81 |
Abt-humira |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
82 |
Abx464 |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
83 |
Abx464 100mg |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
84 |
Abx464 25mg |
- |
- |
- |
- |
097 1件: 97 💬 |
85 |
Abx464 50mg |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
86 |
Accelerated 1 hour-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
87 |
Accelerated 30 minutes-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
88 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
89 |
Acetic acid |
Acetic acid |
1件: D00010 D00010 💬 |
- |
- |
097 1件: 97 💬 |
90 |
Acidophilus |
Lactobacillus acidophilus |
1件: D04349 D04349 💬 |
- |
- |
097 1件: 97 💬 |
91 |
Active group |
- |
- |
- |
- |
097 1件: 97 💬 |
92 |
Adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
93 |
Adipate |
Iron (III) oxide adipate |
- |
- |
- |
097 2件: 97, 228 💬 |
94 |
Adipose derived, autologous mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97 💬 |
95 |
Adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97 💬 |
96 |
Adipose-cord mesenchymal stromal cells (a-mscs) |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
097 1件: 97 💬 |
97 |
Aeb071 |
- |
- |
- |
- |
097 1件: 97 💬 |
98 |
Aeb071a |
- |
- |
- |
- |
097 1件: 97 💬 |
99 |
Ag011 |
- |
- |
- |
- |
097 1件: 97 💬 |
100 |
Ag011 - capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
101 |
Ag011 - enema |
- |
- |
- |
- |
097 1件: 97 💬 |
102 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299 💬 |
103 |
Ajg501 |
- |
- |
- |
- |
097 1件: 97 💬 |
104 |
Ajg511 |
- |
- |
- |
- |
097 1件: 97 💬 |
105 |
Ajm300 |
- |
- |
- |
- |
097 1件: 97 💬 |
106 |
Aldesleukin |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 4件: 49, 65, 96, 97 💬 |
107 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 2件: 96, 97 💬 |
108 |
Alkaline phosphatase |
Alkaline Phosphatase |
- |
- |
- |
046 4件: 46, 93, 97, 172 💬 |
109 |
Allogeneic adipose tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97 💬 |
110 |
Allopurinol |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
111 |
Aloasc |
- |
- |
- |
- |
097 1件: 97 💬 |
112 |
Aloe |
Aloe Vera Leaf |
- |
- |
- |
097 1件: 97 💬 |
113 |
Aloe barbadensis miller |
Aloe Vera Leaf |
- |
- |
- |
097 1件: 97 💬 |
114 |
Alth12-1:4 |
- |
- |
- |
- |
097 1件: 97 💬 |
115 |
Alth12-2:4 |
- |
- |
- |
- |
097 1件: 97 💬 |
116 |
Amg 181 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
117 |
Amg181 |
- |
- |
- |
- |
097 1件: 97 💬 |
118 |
Amgevita |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
119 |
Amgevita (adalimumab biosimilar ) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
120 |
Amgevita 40 mg injektionslösung im fertigpen |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
121 |
Amgevita 40 mg injektionslösung in einer fertigspritze |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
122 |
Amgevita 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
123 |
Amgevita® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
124 |
Aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 2件: 96, 97 💬 |
125 |
Amitriptyline |
Amitriptyline |
2件: D00809 D00809, D07448 D07448 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
078 4件: 78, 97, 226, 299 💬 |
126 |
Amitriptyline hydrochloride |
Amitriptyline |
2件: D00809 D00809, D07448 D07448 💬 |
SLC6A2 2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
097 1件: 97 💬 |
127 |
Amoxicillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 7件: 6 , 46, 63, 96, 97, 222, 299 💬 |
128 |
Amoxicillin and tetracycline |
Amoxicillin |
4件: D00201 D00201, D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
097 1件: 97 💬 |
129 |
Amoxicillin, metronidazole and tetracycline |
Amoxicillin |
7件: D00201 D00201, D00229 D00229, D00409 D00409, D02925 D02925, D05016 D05016, D05017 D05017, D07452 D07452 💬 |
- |
- |
097 1件: 97 💬 |
130 |
Amt |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
131 |
Amt-101 |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
132 |
Amt-101 (oral) |
- |
- |
- |
- |
097 1件: 97 💬 |
133 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
134 |
And (andrographolide) |
Andrographolide |
- |
- |
- |
097 1件: 97 💬 |
135 |
Andecaliximab |
- |
- |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
136 |
Andosan |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
137 |
Andrographis paniculata |
- |
- |
- |
- |
097 1件: 97 💬 |
138 |
Andrographis paniculata (ethanol extract) |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
097 1件: 97 💬 |
139 |
Andrographolide |
Andrographolide |
- |
- |
- |
097 1件: 97 💬 |
140 |
Anrukinzumab |
Anrukinzumab |
1件: D08857 D08857 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
097 1件: 97 💬 |
141 |
Anti beta7 |
- |
- |
- |
- |
097 1件: 97 💬 |
142 |
Anti cd3 monoclonal antibody |
- |
- |
- |
- |
097 1件: 97 💬 |
143 |
Anti tnf therapy including infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
144 |
Anti-cd3 |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
145 |
Anti-cd3 monoclonal antibody |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
146 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
147 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
148 |
Anti-ip-10 antibody |
- |
- |
- |
- |
097 1件: 97 💬 |
149 |
Anti-madcam antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
150 |
Anti-tl1a |
- |
- |
- |
- |
097 1件: 97 💬 |
151 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
152 |
Anti-tnf drug |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
153 |
Anti-tnf therapy |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
154 |
Anti-tnf: infliximab (infusion) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
155 |
Anti-tnf:adalimumab (subcutaneus) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
156 |
Antibiotic cocktail |
- |
- |
- |
- |
097 1件: 97 💬 |
157 |
Aodg (apigenin-7-o-glucuronide) |
Apigenin |
- |
- |
- |
097 1件: 97 💬 |
158 |
Apd334 |
- |
- |
- |
- |
093 4件: 93, 96, 97, 269 💬 |
159 |
Apigenin |
Apigenin |
- |
- |
- |
097 1件: 97 💬 |
160 |
Apixaban |
Apixaban |
1件: D03213 D03213 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 3件: 96, 97, 222 💬 |
161 |
Apixaban 2.5 milligram |
Apixaban |
1件: D03213 D03213 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 2件: 96, 97 💬 |
162 |
Apremilast |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 6件: 46, 50, 56, 97, 162, 271 💬 |
163 |
Apriso 0.375g er cap |
- |
- |
- |
- |
097 1件: 97 💬 |
164 |
Apriso 375 mg extended-release capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
165 |
Apvo210 |
- |
- |
- |
- |
097 1件: 97 💬 |
166 |
Aquamin® |
- |
- |
- |
- |
097 1件: 97 💬 |
167 |
Ar401959 l-arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
096 2件: 96, 97 💬 |
168 |
Arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
169 |
As |
- |
- |
- |
- |
046 6件: 46, 53, 96, 97, 215, 271 💬 |
170 |
As inn |
- |
- |
- |
- |
097 1件: 97 💬 |
171 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251 💬 |
172 |
Asacol |
- |
- |
- |
- |
097 1件: 97 💬 |
173 |
Asacol (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
174 |
Asacol (mesalamine) delayed-release tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
175 |
Asacol 400 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
176 |
Asacol 400 mg (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
177 |
Asacol 400 mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
178 |
Asacol 400mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
179 |
Asacol 800 mg (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
180 |
Asacol 800 mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
181 |
Asacol 800mg tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
182 |
Asacol delayed release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
183 |
Asacol delayed-release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
184 |
Asacol tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
185 |
Asacol® |
- |
- |
- |
- |
097 1件: 97 💬 |
186 |
Asacol® 400 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
187 |
Asc |
- |
- |
- |
- |
036 4件: 36, 51, 96, 97 💬 |
188 |
Ascorbic acid |
Ascorbic acid |
1件: D00018 D00018 💬 |
- |
- |
010 4件: 10, 97, 206, 298 💬 |
189 |
Asp015k |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
190 |
Asp3291 |
- |
- |
- |
- |
097 1件: 97 💬 |
191 |
Aspergillus oryzae |
Aspergillus oryzae |
- |
- |
- |
097 1件: 97 💬 |
192 |
Ast-120 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
193 |
Atl-2502 |
ATL-2502 |
- |
- |
- |
097 1件: 97 💬 |
194 |
Avonex |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
195 |
Avx 470 |
- |
- |
- |
- |
097 1件: 97 💬 |
196 |
Aza |
- |
- |
- |
- |
011 4件: 11, 40, 96, 97 💬 |
197 |
Azafor 50mg |
- |
- |
- |
- |
097 1件: 97 💬 |
198 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
199 |
Azathioprine (aza) |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 19, 97 💬 |
200 |
Azathioprine (aza) or 6-mercaptopurine (6-mp) |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
201 |
Azathioprine (imuran) 50 mg overencapsulated tablet |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
097 1件: 97 💬 |
202 |
Azathioprine and allopurinol |
Allopurinol |
3件: D00224 D00224, D00238 D00238, D03033 D03033 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
097 1件: 97 💬 |
203 |
Azathioprine or 6-mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
204 |
Azatioprina |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 96, 97 💬 |
205 |
B2-asmedic |
- |
- |
- |
- |
097 1件: 97 💬 |
206 |
B: 2 dosis |
- |
- |
- |
- |
097 1件: 97 💬 |
207 |
Bacteriotherapy |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
208 |
Balsalazide |
Balsalazide |
2件: D02715 D02715, D07488 D07488 💬 |
- |
- |
097 1件: 97 💬 |
209 |
Balsalazide disodium |
Balsalazide |
2件: D02715 D02715, D07488 D07488 💬 |
- |
- |
097 1件: 97 💬 |
210 |
Baminercept |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
211 |
Band |
- |
- |
- |
- |
006 2件: 6 , 97 💬 |
212 |
Bascial prescription plus or minus herbs depend on symptoms |
- |
- |
- |
- |
097 1件: 97 💬 |
213 |
Basiliximab |
Basiliximab |
1件: D03058 D03058 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 6件: 2 , 50, 65, 97, 222, 228 💬 |
214 |
Bbt-401-1s |
- |
- |
- |
- |
097 1件: 97 💬 |
215 |
Bbt-401-1s, multiple doses |
- |
- |
- |
- |
097 1件: 97 💬 |
216 |
Bbt-401-1s, single dose |
- |
- |
- |
- |
097 1件: 97 💬 |
217 |
Beclometasone |
- |
- |
- |
- |
097 1件: 97 💬 |
218 |
Beclometasone dipropionate |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
085 2件: 85, 97 💬 |
219 |
Beclomethasone dipropionate |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 2件: 97, 98 💬 |
220 |
Beclomethasone diproprionate |
- |
- |
- |
- |
097 1件: 97 💬 |
221 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
222 |
Behavioral: administration of probiotic (l. rhamnosus and l. acidophilus) |
Lactobacillus acidophilus |
1件: D04349 D04349 💬 |
- |
- |
097 1件: 97 💬 |
223 |
Behavioral: increased dietary intake of salmon or cod |
Salmon, unspecified |
- |
- |
- |
097 1件: 97 💬 |
224 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
225 |
Berberine |
Berberine |
1件: D00092 D00092 💬 |
- |
- |
097 1件: 97 💬 |
226 |
Berberine chloride |
Berberine |
1件: D00092 D00092 💬 |
- |
- |
097 1件: 97 💬 |
227 |
Bertilimumab |
- |
- |
- |
- |
097 2件: 97, 162 💬 |
228 |
Beta-1,3/1,6-d-glucan |
- |
- |
- |
- |
097 1件: 97 💬 |
229 |
Bezlotoxumab |
Bezlotoxumab |
1件: D10453 D10453 💬 |
- |
- |
096 2件: 96, 97 💬 |
230 |
Bg9418 (interferon beta-1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 2件: 13, 97 💬 |
231 |
Bg9924 |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
232 |
Bi 655130 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
233 |
Biap |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
234 |
Bifidobacterium breve |
MRx-4DP0004 |
- |
- |
- |
097 1件: 97 💬 |
235 |
Bifidobacterium infantis |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97 💬 |
236 |
Bifidobacterium infantis 35624 |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97 💬 |
237 |
Bimekizumab |
Bimekizumab |
1件: D11550 D11550 💬 |
IL17A 2件: IL17A, IL17F 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
046 3件: 46, 97, 271 💬 |
238 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
097 1件: 97 💬 |
239 |
Biologically active human fecal microbiota |
- |
- |
- |
- |
097 1件: 97 💬 |
240 |
Biopsies |
- |
- |
- |
- |
097 1件: 97 💬 |
241 |
Biosimilar |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
242 |
Biosimilar infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
243 |
Bitter candytuft fresh plant extract |
- |
- |
- |
- |
097 1件: 97 💬 |
244 |
Bitterschleifenblume-ganzpflanze 1,5ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
245 |
Bl-7040 |
- |
- |
- |
- |
097 1件: 97 💬 |
246 |
Blood sample |
- |
- |
- |
- |
008 13件: 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
247 |
Blood samples |
- |
- |
- |
- |
013 8件: 13, 41, 46, 51, 61, 97, 227, 271 💬 |
248 |
Bms-188667 |
- |
- |
- |
- |
046 8件: 46, 49, 53, 65, 96, 97, 222, 271 💬 |
249 |
Bms-936557 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
250 |
Bms-986165 |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
251 |
Bms-986165 dose 1 |
- |
- |
- |
- |
097 1件: 97 💬 |
252 |
Bms-986165 dose 2 |
- |
- |
- |
- |
097 1件: 97 💬 |
253 |
Bms-986166 |
- |
- |
- |
- |
097 1件: 97 💬 |
254 |
Bms-986184 |
- |
- |
- |
- |
097 1件: 97 💬 |
255 |
Bms986165 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
256 |
Boulardii |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
257 |
Bovine intestinal alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
258 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
259 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
260 |
Brazikumab |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
261 |
Broccoli |
Broccoli |
- |
- |
- |
036 3件: 36, 97, 299 💬 |
262 |
Bt-11 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
263 |
Bt-11 (1000 mg) |
- |
- |
- |
- |
097 1件: 97 💬 |
264 |
Bt-11 (500 mg) |
- |
- |
- |
- |
097 1件: 97 💬 |
265 |
Bt-11 1000mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
266 |
Bt-11 500 mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
267 |
Bt-11 active |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
268 |
Budenofalk 2mg rectal foam |
- |
- |
- |
- |
097 1件: 97 💬 |
269 |
Budenofalk 3mg |
- |
- |
- |
- |
093 2件: 93, 97 💬 |
270 |
Budenofalk rectal foam |
- |
- |
- |
- |
097 1件: 97 💬 |
271 |
Budenofalk® suppositories |
- |
- |
- |
- |
097 1件: 97 💬 |
272 |
Budenofalk® suppositories (bus) |
- |
- |
- |
- |
097 1件: 97 💬 |
273 |
Budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
274 |
Budesonide (6 mg) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
275 |
Budesonide (9 mg) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
276 |
Budesonide 6 mg capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
277 |
Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
278 |
Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
279 |
Budesonide 9 mg capsules, hard (bux-pv) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
280 |
Budesonide 9 mg capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
281 |
Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
282 |
Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
283 |
Budesonide mmx |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
284 |
Budesonide mmx 6 mg tablet |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
285 |
Budesonide mmx® |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
286 |
Budesonide mmx® 6 mg |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
287 |
Budesonide mmx® 9 mg |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
288 |
Budesonide-mmx |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
289 |
Budesonide-mmx® |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
290 |
Budesonide-mmx® 6 mg |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
291 |
Budesonide-mmx® 9 mg |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
292 |
Budesonide-mmx™ |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
293 |
Butanoic acid |
Butyric Acid |
1件: D05866 D05866 💬 |
- |
- |
034 3件: 34, 51, 97 💬 |
294 |
Butyrate |
Butyric Acid |
1件: D05866 D05866 💬 |
- |
- |
097 2件: 97, 291 💬 |
295 |
By demand |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
296 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
297 |
Caffeine 100 mg |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
298 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 2件: 96, 97 💬 |
299 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
300 |
Caltrate pill |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
301 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
302 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
303 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97 💬 |
304 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
305 |
Carbon dioxide |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
050 3件: 50, 51, 97 💬 |
306 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
307 |
Carrageenan |
- |
- |
- |
- |
097 1件: 97 💬 |
308 |
Carvi extractum fluidum |
- |
- |
- |
- |
097 1件: 97 💬 |
309 |
Casein |
Casein |
- |
- |
- |
097 1件: 97 💬 |
310 |
Casein glycomacropeptide (cgmp) |
Casein |
- |
- |
- |
097 1件: 97 💬 |
311 |
Cat-354 |
- |
- |
- |
- |
097 1件: 97 💬 |
312 |
Catridecacog |
Catridecacog |
1件: D10532 D10532 💬 |
- |
- |
097 2件: 97, 288 💬 |
313 |
Cb-01-02 |
- |
- |
- |
- |
097 1件: 97 💬 |
314 |
Cb-01-05-mmx |
- |
- |
- |
- |
097 1件: 97 💬 |
315 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
316 |
Cc-10004 |
- |
- |
- |
- |
046 5件: 46, 56, 97, 162, 271 💬 |
317 |
Cd |
- |
- |
- |
- |
006 6件: 6 , 46, 51, 96, 97, 265 💬 |
318 |
Ceftriaxone |
Ceftriaxone |
2件: D00924 D00924, D07659 D07659 💬 |
- |
- |
002 3件: 2 , 6 , 97 💬 |
319 |
Cefuroxime |
Cefuroxime |
4件: D00262 D00262, D00914 D00914, D00915 D00915, D03431 D03431 💬 |
- |
- |
097 2件: 97, 299 💬 |
320 |
Certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 6件: 37, 46, 96, 97, 226, 271 💬 |
321 |
Cgmp protein |
- |
- |
- |
- |
097 1件: 97 💬 |
322 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
323 |
Chlorogenic acid |
Chlorogenic Acid |
- |
- |
- |
097 1件: 97 💬 |
324 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
325 |
Ciclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
026 13件: 26, 46, 49, 50, 53, 55, 60, 61, 97, 222, 226, 228, 269 💬 |
326 |
Ciclosporina |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
049 3件: 49, 97, 228 💬 |
327 |
Cimzia |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
328 |
Ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
002 5件: 2 , 60, 96, 97, 299 💬 |
329 |
Cla |
- |
- |
- |
- |
097 1件: 97 💬 |
330 |
Cla (chlorogenic acid) |
Chlorogenic Acid |
- |
- |
- |
097 1件: 97 💬 |
331 |
Clarithromycin |
Clarithromycin |
1件: D00276 D00276 💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
332 |
Clipper |
- |
- |
- |
- |
097 1件: 97 💬 |
333 |
Clipper 30 cpr 5mg r.m. |
- |
- |
- |
- |
097 1件: 97 💬 |
334 |
Clipper*30cpr 5mg r.m. |
- |
- |
- |
- |
097 1件: 97 💬 |
335 |
Clotrimazole |
Clotrimazole |
1件: D00282 D00282 💬 |
- |
- |
097 1件: 97 💬 |
336 |
Cnto 148 |
- |
- |
- |
- |
046 4件: 46, 84, 97, 271 💬 |
337 |
Cnto-148 |
- |
- |
- |
- |
097 1件: 97 💬 |
338 |
Cnto1275 |
- |
- |
- |
- |
046 6件: 46, 49, 84, 93, 96, 97 💬 |
339 |
Cnto148 |
- |
- |
- |
- |
046 3件: 46, 84, 97 💬 |
340 |
Cnto1959 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
341 |
Cnto312 |
- |
- |
- |
- |
097 1件: 97 💬 |
342 |
Coamoxiclav |
- |
- |
- |
- |
097 1件: 97 💬 |
343 |
Cobitolimod |
Cobitolimod |
- |
- |
- |
097 1件: 97 💬 |
344 |
Coffee |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
345 |
Coffee coal |
- |
- |
- |
- |
097 1件: 97 💬 |
346 |
Colal pred |
- |
- |
- |
- |
097 1件: 97 💬 |
347 |
Colal-pred |
- |
- |
- |
- |
097 1件: 97 💬 |
348 |
Colal-pred® |
- |
- |
- |
- |
097 1件: 97 💬 |
349 |
Colazide |
- |
- |
- |
- |
097 1件: 97 💬 |
350 |
Coltect |
- |
- |
- |
- |
097 1件: 97 💬 |
351 |
Combination oral budesonide and rectal hydrocortisone |
Budesonide |
2件: D00088 D00088, D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
352 |
Combination product: beclomethasone dipropionate in addition to mc-evoo |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
353 |
Combination product: beclomethasone dipropionate in addition to refined oil |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
354 |
Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
355 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
356 |
Corticosteroids |
- |
- |
- |
- |
041 10件: 41, 46, 49, 64, 97, 107, 164, 220, 296, 300 💬 |
357 |
Corticosteroids only |
- |
- |
- |
- |
097 1件: 97 💬 |
358 |
Cortimentmmx 9 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
359 |
Cosmofer |
- |
- |
- |
- |
086 3件: 86, 96, 97 💬 |
360 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
361 |
Cotrimoxazole |
- |
- |
- |
- |
085 2件: 85, 97 💬 |
362 |
Cp |
- |
- |
- |
- |
006 6件: 6 , 46, 96, 97, 107, 271 💬 |
363 |
Cp- 690 550 |
- |
- |
- |
- |
097 1件: 97 💬 |
364 |
Cp-690,500 5 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
365 |
Cp-690,550 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
366 |
Cp-690,550 10 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
367 |
Cp-690,550-10 |
- |
- |
- |
- |
046 5件: 46, 96, 97, 107, 271 💬 |
368 |
Cp690,550 |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
369 |
Cs (corticosteroids) only |
- |
- |
- |
- |
097 1件: 97 💬 |
370 |
Ct-p13 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
371 |
Ct-p13 sc (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
372 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
373 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
374 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
375 |
Cyclosporine (usan) |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
376 |
Cyclosporine vs infliximab |
Cyclosporine |
2件: D00184 D00184, D02598 D02598 💬 |
PPP3CA 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway |
097 1件: 97 💬 |
377 |
Cycol |
- |
- |
- |
- |
097 1件: 97 💬 |
378 |
Cycol™ |
- |
- |
- |
- |
097 1件: 97 💬 |
379 |
Cytochrome p450 (cyp) substrates |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
380 |
D-proline |
D-Proline |
1件: D00035 D00035 💬 |
- |
- |
097 1件: 97 💬 |
381 |
Daclizumab |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 7件: 13, 56, 60, 65, 97, 283, 284 💬 |
382 |
Dacortin |
- |
- |
- |
- |
097 1件: 97 💬 |
383 |
Dand (14-deoxyandrographolide) |
- |
- |
- |
- |
097 1件: 97 💬 |
384 |
Ddand (14-deoxy-11,12-didehydroandrographolide) |
- |
- |
- |
- |
097 1件: 97 💬 |
385 |
Decortin h |
- |
- |
- |
- |
066 3件: 66, 97, 145 💬 |
386 |
Decortin h 1 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
387 |
Decortin h 10mg |
- |
- |
- |
- |
097 1件: 97 💬 |
388 |
Decortin h 20mg |
- |
- |
- |
- |
097 1件: 97 💬 |
389 |
Decortin h 50 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
390 |
Decortin h 5mg |
- |
- |
- |
- |
097 1件: 97 💬 |
391 |
Dekavil |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
392 |
Dekristol |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
393 |
Delayed and extended release mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
394 |
Deligoparin |
- |
- |
- |
- |
097 1件: 97 💬 |
395 |
Delmitide acetate |
Acetate |
- |
- |
- |
097 1件: 97 💬 |
396 |
Deltacortene |
- |
- |
- |
- |
043 2件: 43, 97 💬 |
397 |
Deltacortene 10 cpr 25mg |
- |
- |
- |
- |
097 1件: 97 💬 |
398 |
Deltacortene 20 cpr 5mg |
- |
- |
- |
- |
097 1件: 97 💬 |
399 |
Deltacortene forte*10cpr 25mg |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
400 |
Deltacortene*20cpr 5mg |
- |
- |
- |
- |
049 3件: 49, 97, 113 💬 |
401 |
Dersalazina sodica |
- |
- |
- |
- |
097 1件: 97 💬 |
402 |
Dersalazine |
Dersalazine |
- |
- |
- |
097 1件: 97 💬 |
403 |
Dersalazine sodium |
Dersalazine |
- |
- |
- |
097 1件: 97 💬 |
404 |
Device: the colonic transendoscopic enteral tubing. |
- |
- |
- |
- |
097 1件: 97 💬 |
405 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
406 |
Dexamethasone 21-phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
407 |
Dextran |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 5件: 2 , 62, 79, 96, 97 💬 |
408 |
Dextran 1 for injection |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
097 1件: 97 💬 |
409 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
410 |
Dextromethorphan 30 mg |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 2件: 96, 97 💬 |
411 |
Diagnostic test: antibodies to golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
412 |
Diagnostic test: calprotectin |
- |
- |
- |
- |
097 1件: 97 💬 |
413 |
Diagnostic test: colonoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
414 |
Diagnostic test: golimumab trough levels |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
415 |
Diagnostic test: histology |
- |
- |
- |
- |
097 1件: 97 💬 |
416 |
Diagnostic test: parasitological diagnostics (coproscopy) |
- |
- |
- |
- |
097 1件: 97 💬 |
417 |
Diagnostic test: rectosigmoidoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
418 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
096 2件: 96, 97 💬 |
419 |
Diet |
- |
- |
- |
- |
097 3件: 97, 240, 299 💬 |
420 |
Dims0150 |
- |
- |
- |
- |
097 1件: 97 💬 |
421 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
422 |
Dukoral |
- |
- |
- |
- |
097 1件: 97 💬 |
423 |
E. coli nissle |
- |
- |
- |
- |
097 1件: 97 💬 |
424 |
E6007 |
- |
- |
- |
- |
097 1件: 97 💬 |
425 |
Ecologic 825 |
- |
- |
- |
- |
097 1件: 97 💬 |
426 |
Egf enema |
- |
- |
- |
- |
097 1件: 97 💬 |
427 |
Eicosapentaenoic acid |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
049 5件: 49, 96, 97, 296, 297 💬 |
428 |
Emea/h/c/000240 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
429 |
Emea/h/c/000481 |
- |
- |
- |
- |
097 1件: 97 💬 |
430 |
En |
- |
- |
- |
- |
006 3件: 6 , 46, 97 💬 |
431 |
Encapsulated faecal microbiota |
- |
- |
- |
- |
097 1件: 97 💬 |
432 |
Encapsulated faecal microbiota filtrate |
- |
- |
- |
- |
097 1件: 97 💬 |
433 |
Encapsulated mesalamine granules (emg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
434 |
Entecavir |
Entecavir |
2件: D04008 D04008, D07896 D07896 💬 |
- |
- |
046 5件: 46, 56, 96, 97, 271 💬 |
435 |
Entocort cr |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
436 |
Entocort ec® 3 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
437 |
Entocort® cr |
- |
- |
- |
- |
097 1件: 97 💬 |
438 |
Entyvio |
- |
- |
- |
- |
094 3件: 94, 96, 97 💬 |
439 |
Entyvio 300 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
440 |
Entyvio 300mg |
- |
- |
- |
- |
097 1件: 97 💬 |
441 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 2件: 96, 97 💬 |
442 |
Epidermal growth factor |
- |
- |
- |
- |
097 1件: 97 💬 |
443 |
Epidermal growth factor enema |
- |
- |
- |
- |
097 1件: 97 💬 |
444 |
Ergocalciferol |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299 💬 |
445 |
Ethanol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 4件: 51, 97, 279, 280 💬 |
446 |
Etrasimod |
Etrasimod |
1件: D10930 D10930 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97 💬 |
447 |
Etrasimod l-arginine |
Arginine |
2件: D02982 D02982, D10930 D10930 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97 💬 |
448 |
Etrolizumab |
Etrolizumab |
1件: D09901 D09901 💬 |
ITGB7 1件: ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 11件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer |
096 2件: 96, 97 💬 |
449 |
Etrozulimab |
- |
- |
- |
- |
097 1件: 97 💬 |
450 |
Exposure to golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
451 |
F8il10 |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
452 |
Factor xiii |
Factor XIII (human) |
- |
- |
- |
051 3件: 51, 97, 288 💬 |
453 |
Faecal matter |
- |
- |
- |
- |
097 1件: 97 💬 |
454 |
Faecal microbiota transplant |
- |
- |
- |
- |
097 1件: 97 💬 |
455 |
Faecal microbiota transplantation |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
456 |
Fe 999301 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
457 |
Fecal microbial transplant |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
458 |
Fecal microbial transplantation |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
459 |
Fecal microbiota |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
460 |
Fecal microbiota capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
461 |
Fecal microbiota enema |
- |
- |
- |
- |
097 1件: 97 💬 |
462 |
Fecal microbiota transplant |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
463 |
Fecal microbiota transplant (fmt) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
464 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 5件: 2 , 66, 94, 96, 97 💬 |
465 |
Fecal microbiota transplantation (fmt) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
466 |
Fecal microbiota transplantation (fmt), openbiome |
- |
- |
- |
- |
097 1件: 97 💬 |
467 |
Ferric carboxymaltose |
Ferric carboxymaltose |
1件: D08920 D08920 💬 |
- |
- |
086 4件: 86, 96, 97, 299 💬 |
468 |
Ferrous sulphate |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
469 |
Filgotinib |
Filgotinib |
1件: D10871 D10871 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 6件: 46, 53, 96, 97, 222, 271 💬 |
470 |
Film-coated tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
471 |
Fitc-adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
472 |
Flagyl |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
473 |
Flaxseed |
- |
- |
- |
- |
097 2件: 97, 299 💬 |
474 |
Flaxseed lignan-enriched complex (flc) |
- |
- |
- |
- |
097 1件: 97 💬 |
475 |
Flixabi |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
476 |
Fluorescein |
Fluorescein |
2件: D01261 D01261, D02024 D02024 💬 |
- |
- |
019 2件: 19, 97 💬 |
477 |
Flupentixol |
Flupentixol |
1件: D01044 D01044 💬 |
DRD1 2件: DRD1, DRD2 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
097 1件: 97 💬 |
478 |
Fmt |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
479 |
Fmt enema |
- |
- |
- |
- |
097 1件: 97 💬 |
480 |
Fmt infusions |
- |
- |
- |
- |
097 1件: 97 💬 |
481 |
Fmt oral |
- |
- |
- |
- |
097 1件: 97 💬 |
482 |
Fosfomycin |
Fosfomycin |
4件: D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 2件: 96, 97 💬 |
483 |
Fp-110 |
- |
- |
- |
- |
097 1件: 97 💬 |
484 |
Fp-cya-050 |
- |
- |
- |
- |
097 1件: 97 💬 |
485 |
Fp-cya-053 |
- |
- |
- |
- |
097 1件: 97 💬 |
486 |
Freeze-dried black raspberry powder |
Raspberry |
- |
- |
- |
097 1件: 97 💬 |
487 |
G321605 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
488 |
Ganciclovir |
Ganciclovir |
2件: D00333 D00333, D04301 D04301 💬 |
- |
- |
028 3件: 28, 60, 97 💬 |
489 |
Gastro-resistant phosphatidylcholine granules |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
490 |
Gb004 |
- |
- |
- |
- |
097 1件: 97 💬 |
491 |
Ged-0301 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
492 |
Ged-0507-34-levo |
GED-0507-34-Levo |
- |
- |
- |
097 1件: 97 💬 |
493 |
Ged-0507-34-levo 160 mg |
GED-0507-34-Levo |
- |
- |
- |
097 1件: 97 💬 |
494 |
Ged-0507-34-levo 80 mg |
GED-0507-34-Levo |
- |
- |
- |
097 1件: 97 💬 |
495 |
Ged0507 |
- |
- |
- |
- |
097 1件: 97 💬 |
496 |
Gelatin |
Gelatin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
028 4件: 28, 78, 97, 269 💬 |
497 |
Genetic: tpmt genotyping |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
498 |
Gi-270384 |
- |
- |
- |
- |
097 1件: 97 💬 |
499 |
Gliolan |
- |
- |
- |
- |
097 1件: 97 💬 |
500 |
Glpg0974 |
- |
- |
- |
- |
097 1件: 97 💬 |
501 |
Glpg1205 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
502 |
Glpg3970 |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
503 |
Glutamine |
L-Glutamine |
1件: D00015 D00015 💬 |
- |
- |
087 7件: 87, 89, 96, 97, 113, 245, 299 💬 |
504 |
Glycyrrhiza |
Glycyrrhiza glabra |
- |
- |
- |
053 2件: 53, 97 💬 |
505 |
Glycyrrhiza glabra |
Glycyrrhiza glabra |
- |
- |
- |
097 1件: 97 💬 |
506 |
Glycyrrhiza glabra root |
Glycyrrhiza glabra |
- |
- |
- |
097 1件: 97 💬 |
507 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
508 |
Golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 6件: 46, 56, 84, 96, 97, 271 💬 |
509 |
Golimumab (glm) |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
510 |
Golimumab (optimization) |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
511 |
Golimumab 1 mg per kg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
512 |
Golimumab 100 mg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 97 💬 |
513 |
Golimumab 2 mg per kg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
514 |
Golimumab 200 mg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
515 |
Golimumab 4 mg per kg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
516 |
Golimumab 400 mg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
517 |
Golimumab 50 mg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 97 💬 |
518 |
Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
519 |
Golimumab dose 1 |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
520 |
Golimumab dose 2 |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
521 |
Golimumab liquid in prefilled syringe |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 84, 97 💬 |
522 |
Golimumab liquid in vial |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 97, 271 💬 |
523 |
Golimumab prefilled syringe |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
524 |
Golimumab treatment optimization. |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
525 |
Gralise |
- |
- |
- |
- |
097 2件: 97, 226 💬 |
526 |
Granulated mesalamine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
527 |
Grapefruit |
Grapefruit |
- |
- |
- |
006 5件: 6 , 46, 50, 83, 97 💬 |
528 |
Group 1- control diet |
- |
- |
- |
- |
097 1件: 97 💬 |
529 |
Group 2- ucd diet |
- |
- |
- |
- |
097 1件: 97 💬 |
530 |
Gs-4875 |
- |
- |
- |
- |
097 1件: 97 💬 |
531 |
Gs-5745 |
GS-5745 |
- |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
532 |
Gs-5745 iv |
GS-5745 |
- |
- |
- |
097 1件: 97 💬 |
533 |
Gs-5745 sc |
GS-5745 |
- |
- |
- |
097 1件: 97 💬 |
534 |
Gs-6034 |
- |
- |
- |
- |
046 4件: 46, 53, 96, 97 💬 |
535 |
Gsk1399686 |
- |
- |
- |
- |
097 1件: 97 💬 |
536 |
Gsk1605786 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
537 |
Gsk1605786a |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
538 |
Gsk2586184 400mg |
- |
- |
- |
- |
097 1件: 97 💬 |
539 |
Gsk2831781 |
- |
- |
- |
- |
097 1件: 97 💬 |
540 |
Gsk2831781 iv infusion |
- |
- |
- |
- |
097 1件: 97 💬 |
541 |
Gsk2831781 sc injection |
- |
- |
- |
- |
097 1件: 97 💬 |
542 |
Gsk2982772 |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
543 |
Gsk2982772a, where a denotes the free base |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
544 |
Guaiazulene |
Guaiazulen |
- |
- |
- |
097 1件: 97 💬 |
545 |
Guselkum |
- |
- |
- |
- |
097 1件: 97 💬 |
546 |
Guselkumab |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 41, 96, 97 💬 |
547 |
Guselkumab dose 1 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
548 |
Guselkumab dose 2 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
549 |
Gwp42003 |
- |
- |
- |
- |
097 1件: 97 💬 |
550 |
H02ab |
- |
- |
- |
- |
097 1件: 97 💬 |
551 |
He3286 |
HE3286 |
- |
- |
- |
046 2件: 46, 97 💬 |
552 |
Hemay007 |
- |
- |
- |
- |
097 1件: 97 💬 |
553 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
554 |
Herbal treatment (sa100) |
- |
- |
- |
- |
097 1件: 97 💬 |
555 |
Hextend |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
556 |
Hf2 |
- |
- |
- |
- |
097 1件: 97 💬 |
557 |
Hgd40 |
- |
- |
- |
- |
097 1件: 97 💬 |
558 |
Hgs1025 |
- |
- |
- |
- |
097 1件: 97 💬 |
559 |
High dose |
- |
- |
- |
- |
097 1件: 97 💬 |
560 |
High dose budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
561 |
Hmpl-004 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
562 |
Hmpl-004 1800 mg/day |
- |
- |
- |
- |
097 1件: 97 💬 |
563 |
Hmpl-004 2400 mg/day |
- |
- |
- |
- |
097 1件: 97 💬 |
564 |
Hmpl-004 high dose |
- |
- |
- |
- |
097 1件: 97 💬 |
565 |
Hmpl-004 low dose |
- |
- |
- |
- |
097 1件: 97 💬 |
566 |
Hmpl004-6599 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
567 |
Hulio |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
568 |
Hum291 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
569 |
Hum291) |
- |
- |
- |
- |
097 1件: 97 💬 |
570 |
Human anti-ip10 monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
571 |
Human anti-tnf igg1 monoclonal antibody |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
572 |
Human anti-tnf-alpha monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
573 |
Human anti-tnfalfa |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
574 |
Humanized recombinant igg4 monoclonal antibody against cd-127 |
- |
- |
- |
- |
097 1件: 97 💬 |
575 |
Humira |
- |
- |
- |
- |
046 7件: 46, 84, 96, 97, 160, 269, 271 💬 |
576 |
Humira (adalimumab original) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
577 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
578 |
Humira 40 mg solution for injection in pre-filled syringes |
- |
- |
- |
- |
097 1件: 97 💬 |
579 |
Humira 40 mg/0.8 ml solution for injection |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
580 |
Humira 40 mg/0.8 ml solution for injection for paediatric use |
- |
- |
- |
- |
097 1件: 97 💬 |
581 |
Humira 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
582 |
Humira ® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
583 |
Humira® |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
584 |
Hyaluronate |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
053 2件: 53, 97 💬 |
585 |
Hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
586 |
Hydrocortisone acetate |
Acetate |
2件: D00088 D00088, D00165 D00165 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
587 |
Hydrocortisone sodium succinate |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 3件: 81, 83, 97 💬 |
588 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
589 |
Hydroxide |
Hydroxide ion |
- |
- |
- |
046 4件: 46, 96, 97, 284 💬 |
590 |
Hydroxocobalamin |
Hydroxocobalamin |
3件: D01027 D01027, D02707 D02707, D04929 D04929 💬 |
- |
- |
097 1件: 97 💬 |
591 |
Hydroxocobalamin with butyrate |
Butyric Acid |
4件: D01027 D01027, D02707 D02707, D04929 D04929, D05866 D05866 💬 |
- |
- |
097 1件: 97 💬 |
592 |
Ibd98-m |
- |
- |
- |
- |
097 1件: 97 💬 |
593 |
Ibd98-m delayed-release capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
594 |
Iberogast n |
- |
- |
- |
- |
097 1件: 97 💬 |
595 |
Idoform®travel |
- |
- |
- |
- |
097 1件: 97 💬 |
596 |
Im90838 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
597 |
Imolope |
- |
- |
- |
- |
097 1件: 97 💬 |
598 |
Impact |
- |
- |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
599 |
Imu-838 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
600 |
Imuran |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
601 |
Imurek |
- |
- |
- |
- |
097 1件: 97 💬 |
602 |
Imurek 25mg filmtabletten |
- |
- |
- |
- |
097 1件: 97 💬 |
603 |
Imurek 50mg filmtabletten |
- |
- |
- |
- |
097 1件: 97 💬 |
604 |
Imurel |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97 💬 |
605 |
Incb039110 |
- |
- |
- |
- |
051 2件: 51, 97 💬 |
606 |
Inflectra |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
607 |
Inflectra 100 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
608 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
609 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
610 |
Infliximab (ifx) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
611 |
Infliximab 10 mg/kg |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
612 |
Infliximab 5 mg/kg |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
613 |
Infliximab [infliximab biosimilar 3] |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 4件: 37, 46, 96, 97 💬 |
614 |
Infliximab and adalimumab |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
615 |
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab |
Adalimumab |
5件: D02597 D02597, D02598 D02598, D04358 D04358, D08083 D08083, D09214 D09214 💬 |
IL12A 6件: IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
616 |
Infliximab, adalimumab, certolizumab pegol |
Adalimumab |
3件: D02597 D02597, D02598 D02598, D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
617 |
Innovator infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
618 |
Inositol |
Inositol |
1件: D08079 D08079 💬 |
- |
- |
096 2件: 96, 97 💬 |
619 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 5件: 13, 20, 26, 96, 97 💬 |
620 |
Interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 4件: 13, 26, 96, 97 💬 |
621 |
Interferon-beta |
Human interferon beta |
- |
- |
- |
013 2件: 13, 97 💬 |
622 |
Interferon-beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 2件: 13, 97 💬 |
623 |
Interferon-beta-1a, 44 microgram |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
097 1件: 97 💬 |
624 |
Interferon-beta-1a, 66 microgram |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
097 1件: 97 💬 |
625 |
Interleukin 2 |
- |
- |
- |
- |
046 9件: 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
626 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 8件: 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
627 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 2件: 96, 97 💬 |
628 |
Iron |
Iron |
- |
- |
- |
018 5件: 18, 96, 97, 254, 284 💬 |
629 |
Iron sucrose |
Iron |
2件: D00025 D00025, D04616 D04616 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
630 |
Iron sulphate |
Iron |
- |
- |
- |
096 2件: 96, 97 💬 |
631 |
Iron sulphate 200mg coated tablets |
Iron |
- |
- |
- |
096 2件: 96, 97 💬 |
632 |
Iron supplement 300-600 mg/day |
Iron |
- |
- |
- |
096 2件: 96, 97 💬 |
633 |
Iron(iii)- hydroxide dextran complex |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
096 2件: 96, 97 💬 |
634 |
Itacitinib |
Itacitinib |
1件: D10944 D10944 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 5件: 46, 51, 60, 97, 228 💬 |
635 |
Itacitinib adipate |
Iron (III) oxide adipate |
1件: D10944 D10944 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 2件: 97, 228 💬 |
636 |
Iv corticosteroid |
- |
- |
- |
- |
097 1件: 97 💬 |
637 |
Jnj-54781532 150 mg once daily |
- |
- |
- |
- |
097 1件: 97 💬 |
638 |
Jnj-54781532 25 mg once daily |
- |
- |
- |
- |
097 1件: 97 💬 |
639 |
Jnj-54781532 75 mg once daily |
- |
- |
- |
- |
097 1件: 97 💬 |
640 |
Jnj-54781532 75 mg twice daily |
- |
- |
- |
- |
097 1件: 97 💬 |
641 |
Jnj-54781532-aad-10 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
642 |
Jnj-54781532-aad-30 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
643 |
Jnj-54781532-aad-5 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
644 |
Jnj-66525433 |
- |
- |
- |
- |
097 1件: 97 💬 |
645 |
K(d)pt |
- |
- |
- |
- |
097 1件: 97 💬 |
646 |
Kamillenblüten 3ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
647 |
Kappaproct |
- |
- |
- |
- |
097 1件: 97 💬 |
648 |
Kdpt |
- |
- |
- |
- |
097 1件: 97 💬 |
649 |
Khk4083 |
- |
- |
- |
- |
097 1件: 97 💬 |
650 |
Kremezin |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
651 |
Kremezin®, spherical adsorptive carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
096 2件: 96, 97 💬 |
652 |
Krp203 |
- |
- |
- |
- |
097 1件: 97 💬 |
653 |
Krp203a |
- |
- |
- |
- |
097 1件: 97 💬 |
654 |
Kyo-dophilus |
- |
- |
- |
- |
097 1件: 97 💬 |
655 |
Kümmel 2ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
656 |
L-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 6件: 13, 96, 97, 265, 298, 316 💬 |
657 |
L-lysyl-d-prolyl-l-threonine acetate |
Acetate |
1件: D00041 D00041 💬 |
- |
- |
097 1件: 97 💬 |
658 |
L-lysyl-d-prolyl-lthreonine acetate, lyophilisate |
Acetate |
- |
- |
- |
097 1件: 97 💬 |
659 |
Lactated ringers |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
660 |
Lactobacillus casei dg |
- |
- |
- |
- |
097 1件: 97 💬 |
661 |
Lactobacillus gg |
- |
- |
- |
- |
097 1件: 97 💬 |
662 |
Lactobacillus plantarum |
Lactobacillus plantarum |
- |
- |
- |
006 3件: 6 , 97, 156 💬 |
663 |
Lactobacillus reuteri |
Lactobacillus reuteri |
- |
- |
- |
097 2件: 97, 299 💬 |
664 |
Lactobacillus rhamnosus gg atcc 53103 |
- |
- |
- |
- |
097 1件: 97 💬 |
665 |
Lactobacillus salivarius ucc118 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
666 |
Lactobacilus acidophilus & bifidobacterium animalis/lactis |
Lactobacillus acidophilus |
1件: D04349 D04349 💬 |
- |
- |
097 1件: 97 💬 |
667 |
Lactose |
Lactose |
2件: D00046 D00046, D03226 D03226 💬 |
- |
- |
002 6件: 2 , 6 , 13, 97, 228, 310 💬 |
668 |
Lactose in water |
Lactose |
3件: D00001 D00001, D00046 D00046, D03226 D03226 💬 |
- |
- |
097 1件: 97 💬 |
669 |
Lc51-0255 |
- |
- |
- |
- |
097 1件: 97 💬 |
670 |
Ldp-02 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
671 |
Leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 10件: 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
672 |
Levocarnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 3件: 3 , 53, 97 💬 |
673 |
Levocarnitine propyl hydrochloride |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
674 |
Linaclotide |
Linaclotide |
1件: D09355 D09355 💬 |
GUCY2C 1件: GUCY2C 💬 |
Metabolic pathways 2件: Metabolic pathways, Purine metabolism |
097 1件: 97 💬 |
675 |
Lixacol |
- |
- |
- |
- |
097 1件: 97 💬 |
676 |
Loperamide |
Loperamide |
3件: D00729 D00729, D07113 D07113, D08144 D08144 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 2件: 13, 97 💬 |
677 |
Loperamide hydrochloride |
Loperamide |
3件: D00729 D00729, D07113 D07113, D08144 D08144 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
678 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
679 |
Low dose |
- |
- |
- |
- |
097 1件: 97 💬 |
680 |
Low dose budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
681 |
Low dose naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
682 |
Low fodmap |
- |
- |
- |
- |
097 1件: 97 💬 |
683 |
Lt-02 |
- |
- |
- |
- |
097 1件: 97 💬 |
684 |
Lt-02 (modified-release pc pellets) |
- |
- |
- |
- |
097 1件: 97 💬 |
685 |
Lumbar puncture |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
686 |
Lx1606 |
- |
- |
- |
- |
097 1件: 97 💬 |
687 |
Ly3074828 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
688 |
Lyc-30937 |
- |
- |
- |
- |
097 1件: 97 💬 |
689 |
Lyc-30937-ec |
- |
- |
- |
- |
097 1件: 97 💬 |
690 |
Lys006 |
- |
- |
- |
- |
097 1件: 97 💬 |
691 |
Lysine |
L-Lysine |
1件: D02304 D02304 💬 |
- |
- |
013 4件: 13, 97, 228, 299 💬 |
692 |
Lysine-d-proline-threonine |
D-Proline |
3件: D00035 D00035, D00041 D00041, D02304 D02304 💬 |
- |
- |
097 1件: 97 💬 |
693 |
Magnesium |
Magnesium |
- |
- |
- |
006 16件: 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
694 |
Magnesium citrate |
Magnesium |
1件: D03265 D03265 💬 |
- |
- |
097 1件: 97 💬 |
695 |
Maltodextrin |
Maltodextrin |
1件: D02329 D02329 💬 |
- |
- |
006 4件: 6 , 13, 96, 97 💬 |
696 |
Maltose |
Maltose |
1件: D00044 D00044 💬 |
- |
- |
096 2件: 96, 97 💬 |
697 |
Mango |
Mango |
- |
- |
- |
096 2件: 96, 97 💬 |
698 |
Mango polyphenolics |
Mango |
- |
- |
- |
096 2件: 96, 97 💬 |
699 |
Mare´s milk |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
700 |
Matricaria flower |
Chamomile |
1件: D09212 D09212 💬 |
- |
- |
097 1件: 97 💬 |
701 |
Matricaria recutita l. flos |
- |
- |
- |
- |
097 1件: 97 💬 |
702 |
Maximal oral 5asa |
- |
- |
- |
- |
097 1件: 97 💬 |
703 |
Md-0901 |
- |
- |
- |
- |
097 1件: 97 💬 |
704 |
Mdx-1100 |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
705 |
Mdx-1100 (anti-cxcl10 human monoclonal antibody) |
- |
- |
- |
- |
097 1件: 97 💬 |
706 |
Medi7183 high dose |
- |
- |
- |
- |
097 1件: 97 💬 |
707 |
Medi7183 low dose |
- |
- |
- |
- |
097 1件: 97 💬 |
708 |
Medi7183 medium dose |
- |
- |
- |
- |
097 1件: 97 💬 |
709 |
Melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
710 |
Melissae folii dry aqueous extract |
- |
- |
- |
- |
097 1件: 97 💬 |
711 |
Melissenblätter 15ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
712 |
Melitracen |
Melitracen |
1件: D08171 D08171 💬 |
- |
- |
097 1件: 97 💬 |
713 |
Mentha × piperita l. folium |
- |
- |
- |
- |
097 1件: 97 💬 |
714 |
Mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 3件: 96, 97, 164 💬 |
715 |
Mercaptopurine (puri-nethol) |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 1件: 97 💬 |
716 |
Mercaptopurine (purinethol) |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 1件: 97 💬 |
717 |
Mesalamin |
- |
- |
- |
- |
097 1件: 97 💬 |
718 |
Mesalamine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 3件: 96, 97, 164 💬 |
719 |
Mesalamine delayed release tablets 400mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
720 |
Mesalamine enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
721 |
Mesalamine granules |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
722 |
Mesalamine once-daily |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
723 |
Mesalamine twice-daily |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
724 |
Mesalamine, 5-aminosalicylic acid [5-asa] |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
725 |
Mesalamine, 5-asa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
726 |
Mesalazina |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
727 |
Mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
046 3件: 46, 96, 97 💬 |
728 |
Mesalazine (3,600 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
729 |
Mesalazine (asacol®) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
730 |
Mesalazine - tid 1000 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
731 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
732 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
733 |
Mesalazine 250mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
734 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
2件: D00377 D00377, D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
735 |
Mesalazine 4g enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
736 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
737 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
738 |
Mesalazine enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
739 |
Mesalazine liquid enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
740 |
Mesalazine slow-release granules |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
741 |
Mesalazine tablet |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
742 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
2件: D00088 D00088, D00377 D00377 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
743 |
Mesalazinum |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
744 |
Mesenchymal cells |
- |
- |
- |
- |
097 1件: 97 💬 |
745 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 9件: 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
746 |
Met-2 |
- |
- |
- |
- |
097 1件: 97 💬 |
747 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
748 |
Methotrexate bellon |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 1件: 97 💬 |
749 |
Methotrexate bellon 25mg/ml |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 1件: 97 💬 |
750 |
Methotrexate disodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 3件: 46, 96, 97 💬 |
751 |
Methotrexate injection |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 2件: 96, 97 💬 |
752 |
Methylene blue |
Methylene blue |
2件: D02312 D02312, D10537 D10537 💬 |
- |
- |
097 1件: 97 💬 |
753 |
Methylene blue 25mg tablets |
Methylene blue |
2件: D02312 D02312, D10537 D10537 💬 |
- |
- |
097 1件: 97 💬 |
754 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
755 |
Methylprednisolone sodium hemisuccinate |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 97 💬 |
756 |
Metoject |
- |
- |
- |
- |
041 4件: 41, 46, 96, 97 💬 |
757 |
Metronidazole |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬 |
758 |
Metronidazole capsule 50 mg |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 1件: 97 💬 |
759 |
Mezavant |
- |
- |
- |
- |
097 1件: 97 💬 |
760 |
Mezavant 1200 mg magensaftresistente retardtabletten |
- |
- |
- |
- |
097 1件: 97 💬 |
761 |
Mezavant gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
762 |
Mezavant xl |
- |
- |
- |
- |
097 1件: 97 💬 |
763 |
Mezavant xl 1200 mg gastro-resistant prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
764 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
765 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets. |
- |
- |
- |
- |
097 1件: 97 💬 |
766 |
Mezavant xl 1200mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
767 |
Mezavant xl gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
768 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
769 |
Midazolam 2 mg |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
096 2件: 96, 97 💬 |
770 |
Mirikizumab |
Mirikizumab |
1件: D11123 D11123 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 3件: 37, 96, 97 💬 |
771 |
Mirikizumab iv |
Mirikizumab |
1件: D11123 D11123 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 1件: 97 💬 |
772 |
Mirikizumab sc |
Mirikizumab |
1件: D11123 D11123 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 1件: 97 💬 |
773 |
Mitoq |
- |
- |
- |
- |
006 3件: 6 , 13, 97 💬 |
774 |
Mk-8259 |
- |
- |
- |
- |
097 1件: 97 💬 |
775 |
Mln0002 |
- |
- |
- |
- |
094 3件: 94, 96, 97 💬 |
776 |
Mln0002 (vedolizumab) |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
777 |
Mln0002 sc |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
778 |
Mln002 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
779 |
Mmx mesalamine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
780 |
Mmx mesalamine/ mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
781 |
Mmx mesalamine/mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
782 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
783 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
784 |
Modified gegen qinlian decoction |
- |
- |
- |
- |
097 1件: 97 💬 |
785 |
Modified-release phosphatidylcholine |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
786 |
Mongersen |
Mongersen |
1件: D10956 D10956 💬 |
SMAD7 1件: SMAD7 💬 |
Hippo signaling pathway 2件: Hippo signaling pathway, TGF-beta signaling pathway |
096 2件: 96, 97 💬 |
787 |
Monoclonal antibody anti-igg1 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
788 |
Msc |
- |
- |
- |
- |
006 6件: 6 , 51, 60, 96, 97, 271 💬 |
789 |
Mtx |
- |
- |
- |
- |
035 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
790 |
Mtx 12.5 |
- |
- |
- |
- |
097 1件: 97 💬 |
791 |
Mtx 25 |
- |
- |
- |
- |
097 1件: 97 💬 |
792 |
Multiple dose- group b |
- |
- |
- |
- |
097 1件: 97 💬 |
793 |
Multiple dose-group b |
- |
- |
- |
- |
097 1件: 97 💬 |
794 |
Multistem |
MultiStem |
- |
- |
- |
097 1件: 97 💬 |
795 |
Multistem high dose |
MultiStem |
- |
- |
- |
097 1件: 97 💬 |
796 |
Multistem low dose |
MultiStem |
- |
- |
- |
097 1件: 97 💬 |
797 |
Mycodigest supplement |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
798 |
Myrrh |
Myrrh |
1件: D08948 D08948 💬 |
- |
- |
097 1件: 97 💬 |
799 |
Myrrhinil-intest® |
- |
- |
- |
- |
097 1件: 97 💬 |
800 |
N.a. |
- |
- |
- |
- |
003 10件: 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
801 |
Naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 12件: 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
802 |
Nand (neoandrographolide) |
- |
- |
- |
- |
097 1件: 97 💬 |
803 |
Nanocort |
- |
- |
- |
- |
013 3件: 13, 46, 97 💬 |
804 |
Nd |
- |
- |
- |
- |
013 4件: 13, 46, 51, 97 💬 |
805 |
Neomycin |
Neomycin |
1件: D08260 D08260 💬 |
- |
- |
096 3件: 96, 97, 296 💬 |
806 |
Neoral |
- |
- |
- |
- |
060 3件: 60, 97, 222 💬 |
807 |
Neoral soft gelatin capsules |
Gelatin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
097 2件: 97, 269 💬 |
808 |
Niclosamide |
Niclosamide |
1件: D00436 D00436 💬 |
- |
- |
046 2件: 46, 97 💬 |
809 |
Nicolon |
- |
- |
- |
- |
097 1件: 97 💬 |
810 |
Nitazoxanide |
Nitazoxanide |
1件: D02486 D02486 💬 |
- |
- |
096 2件: 96, 97 💬 |
811 |
Nitazoxanide 500mg oral tablet |
Nitazoxanide |
1件: D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
812 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
813 |
Nolpitantium besylate |
- |
- |
- |
- |
097 1件: 97 💬 |
814 |
Non as of yet |
- |
- |
- |
- |
097 1件: 97 💬 |
815 |
None |
- |
- |
- |
- |
046 14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
816 |
None given |
- |
- |
- |
- |
097 1件: 97 💬 |
817 |
Normal saline enema |
- |
- |
- |
- |
097 1件: 97 💬 |
818 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
819 |
Nutrition supplement |
- |
- |
- |
- |
097 1件: 97 💬 |
820 |
Nutritional dietary intervention |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
821 |
Nuvion®) |
- |
- |
- |
- |
097 1件: 97 💬 |
822 |
Nx-13 250 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
823 |
Oats |
Oat |
- |
- |
- |
097 1件: 97 💬 |
824 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
825 |
Omeprazole 20 mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 2件: 96, 97 💬 |
826 |
Ondansetron |
Ondansetron |
2件: D00456 D00456, D00678 D00678 💬 |
HTR3A 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Taste transduction |
006 3件: 6 , 97, 231 💬 |
827 |
Ondansetron hydrochloride dihydrate |
Ondansetron |
2件: D00456 D00456, D00678 D00678 💬 |
HTR3A 5件: HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Taste transduction |
006 2件: 6 , 97 💬 |
828 |
Ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
829 |
Opc-6535 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
830 |
Opc-6535 tablets (drug) |
- |
- |
- |
- |
097 1件: 97 💬 |
831 |
Opc-6535(tetomilast) |
Tetomilast |
- |
- |
- |
096 2件: 96, 97 💬 |
832 |
Oprx-106 |
- |
- |
- |
- |
097 1件: 97 💬 |
833 |
Oprx-106 (plant cells expressing tnfr-fc) 2mg |
- |
- |
- |
- |
097 1件: 97 💬 |
834 |
Oprx-106 (plant cells expressing tnfr-fc) 8mg |
- |
- |
- |
- |
097 1件: 97 💬 |
835 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
7件: D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
836 |
Oral corticosteroids |
- |
- |
- |
- |
013 3件: 13, 46, 97 💬 |
837 |
Oral okt3 |
- |
- |
- |
- |
097 1件: 97 💬 |
838 |
Ore1001 |
- |
- |
- |
- |
097 1件: 97 💬 |
839 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
840 |
Originator (legacy) drug |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
841 |
Ose-127 |
- |
- |
- |
- |
053 2件: 53, 97 💬 |
842 |
Oseltamivir |
Oseltamivir |
2件: D00900 D00900, D08306 D08306 💬 |
- |
- |
097 2件: 97, 299 💬 |
843 |
Ost-122 |
- |
- |
- |
- |
097 1件: 97 💬 |
844 |
Other: 0 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
845 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
846 |
Other: additional therapies |
- |
- |
- |
- |
097 1件: 97 💬 |
847 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
848 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 1件: 97 💬 |
849 |
Other: conventional drugs |
- |
- |
- |
- |
097 1件: 97 💬 |
850 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 1件: 97 💬 |
851 |
Other: e-monitoring |
- |
- |
- |
- |
097 1件: 97 💬 |
852 |
Other: faecal bacterial transplantation |
- |
- |
- |
- |
097 1件: 97 💬 |
853 |
Other: fast mimicking diet |
- |
- |
- |
- |
097 1件: 97 💬 |
854 |
Other: hyperbaric oxygen therapy |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
097 2件: 97, 226 💬 |
855 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 1件: 97 💬 |
856 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
857 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
858 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
859 |
Other: mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
860 |
Other: other biologic agents |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
861 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
862 |
Other: pretreatment antibiotics |
- |
- |
- |
- |
097 1件: 97 💬 |
863 |
Other: saline |
- |
- |
- |
- |
002 8件: 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
864 |
Other: therapy education |
- |
- |
- |
- |
097 1件: 97 💬 |
865 |
Other: threonine |
Threonine |
1件: D00041 D00041 💬 |
- |
- |
096 2件: 96, 97 💬 |
866 |
Other: ulcerative colitis diet |
- |
- |
- |
- |
097 1件: 97 💬 |
867 |
Overencapsulated azathioprine (imuran) 50 mg tablet |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
097 1件: 97 💬 |
868 |
Overencapsulated mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
869 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
870 |
Ozanimod |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 96, 97 💬 |
871 |
Ozanimod hydrochloride |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 96, 97 💬 |
872 |
Palmitoleic acid |
Palmitoleic Acid |
- |
- |
- |
097 1件: 97 💬 |
873 |
Parnaparin |
Parnaparin |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
097 1件: 97 💬 |
874 |
Parnaparin sodium |
Parnaparin |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
097 1件: 97 💬 |
875 |
Pbf-677 |
- |
- |
- |
- |
097 1件: 97 💬 |
876 |
Pct (purecell technologies complex) |
- |
- |
- |
- |
097 1件: 97 💬 |
877 |
Peg |
- |
- |
- |
- |
006 9件: 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
878 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 97 💬 |
879 |
Pending |
- |
- |
- |
- |
013 6件: 13, 19, 96, 97, 113, 302 💬 |
880 |
Pentasa |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
881 |
Pentasa 2g sachet prolonged release granules (95%) |
- |
- |
- |
- |
097 1件: 97 💬 |
882 |
Pentasa 500 mg retardtabletten |
- |
- |
- |
- |
097 1件: 97 💬 |
883 |
Pentasa compact 2g, granulate with prolonged release |
- |
- |
- |
- |
097 1件: 97 💬 |
884 |
Pentasa compact 4g, granulate with prolonged release |
- |
- |
- |
- |
097 1件: 97 💬 |
885 |
Pentasa enema |
- |
- |
- |
- |
097 1件: 97 💬 |
886 |
Pentasa prolonged release granules 2g |
- |
- |
- |
- |
097 1件: 97 💬 |
887 |
Pentasa sachet |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
888 |
Pentasa sachet 1 g |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
889 |
Pentasa sachet 1g |
- |
- |
- |
- |
097 1件: 97 💬 |
890 |
Pentasa sachet 2 g |
- |
- |
- |
- |
097 1件: 97 💬 |
891 |
Pf 06687234 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
892 |
Pf-00547659 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
893 |
Pf-00547659 sc injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
894 |
Pf-05230917 |
- |
- |
- |
- |
097 1件: 97 💬 |
895 |
Pf-05285401 |
- |
- |
- |
- |
097 1件: 97 💬 |
896 |
Pf-06480605 |
- |
- |
- |
- |
097 1件: 97 💬 |
897 |
Pf-06480605 100 mg/ml |
- |
- |
- |
- |
097 1件: 97 💬 |
898 |
Pf-06651600 |
PF-06651600 |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
899 |
Pf-06651600 10 mg |
PF-06651600 |
- |
- |
- |
097 1件: 97 💬 |
900 |
Pf-06651600 50 mg |
PF-06651600 |
- |
- |
- |
096 2件: 96, 97 💬 |
901 |
Pf-06651600-15 |
PF-06651600 |
- |
- |
- |
096 2件: 96, 97 💬 |
902 |
Pf-06687234 |
- |
- |
- |
- |
097 1件: 97 💬 |
903 |
Pf-06700841 |
PF-06700841 |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
904 |
Pf-06700841 25 mg |
PF-06700841 |
- |
- |
- |
096 2件: 96, 97 💬 |
905 |
Pf-06700841 5 mg |
PF-06700841 |
- |
- |
- |
096 2件: 96, 97 💬 |
906 |
Pf-06700841-15 |
PF-06700841 |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
907 |
Pf-06826647 |
- |
- |
- |
- |
097 1件: 97 💬 |
908 |
Pf-06826647 100 mg qd |
- |
- |
- |
- |
097 1件: 97 💬 |
909 |
Pf-06826647 300 mg qd |
- |
- |
- |
- |
097 1件: 97 💬 |
910 |
Pf-06826647 600 mg qd |
- |
- |
- |
- |
097 1件: 97 💬 |
911 |
Pf-6826647 400 mg qd |
- |
- |
- |
- |
097 1件: 97 💬 |
912 |
Pfefferminzblätter 1ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
913 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
914 |
Phosphatidylcholine |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
915 |
Photodynamic therapy with gliolan |
- |
- |
- |
- |
097 1件: 97 💬 |
916 |
Picosulfate |
Picosulfuric acid |
- |
- |
- |
097 2件: 97, 291 💬 |
917 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
918 |
Pn-10884a |
- |
- |
- |
- |
097 1件: 97 💬 |
919 |
Pn-943 |
- |
- |
- |
- |
097 1件: 97 💬 |
920 |
Polaprezinc |
Polaprezinc |
1件: D01611 D01611 💬 |
- |
- |
096 2件: 96, 97 💬 |
921 |
Polyethylene glycol |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
096 5件: 96, 97, 235, 276, 299 💬 |
922 |
Polyphenon e® |
- |
- |
- |
- |
097 1件: 97 💬 |
923 |
Pomegranate |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
924 |
Prd5973697 |
- |
- |
- |
- |
097 1件: 97 💬 |
925 |
Prednisolon |
- |
- |
- |
- |
046 6件: 46, 50, 51, 66, 96, 97 💬 |
926 |
Prednisolon jenapharm |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
927 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
928 |
Prednisolone sodium metasulphobenzoate |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
929 |
Prednisolone sodium phosphate |
Phosphate ion |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 2件: 13, 97 💬 |
930 |
Prednisolone tablets b.p. 5mg |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
931 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
932 |
Prefilled syringe delivery of golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
933 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
934 |
Prim-dj2727 |
- |
- |
- |
- |
006 2件: 6 , 97 💬 |
935 |
Pro145223 |
- |
- |
- |
- |
097 1件: 97 💬 |
936 |
Pro145223 (ro5490261) |
- |
- |
- |
- |
097 1件: 97 💬 |
937 |
Probiotic |
- |
- |
- |
- |
002 7件: 2 , 6 , 93, 96, 97, 193, 266 💬 |
938 |
Probiotic formula capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
939 |
Probiotic mixture |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
940 |
Probiotics |
- |
- |
- |
- |
094 4件: 94, 96, 97, 291 💬 |
941 |
Procedure: biopsies |
- |
- |
- |
- |
097 1件: 97 💬 |
942 |
Procedure: blood sampling, endoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
943 |
Procedure: colectomy |
- |
- |
- |
- |
097 1件: 97 💬 |
944 |
Procedure: colonoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
945 |
Procedure: colorectal biopsies |
- |
- |
- |
- |
097 1件: 97 💬 |
946 |
Procedure: enema |
- |
- |
- |
- |
097 1件: 97 💬 |
947 |
Procedure: fecal microbiota transplantation |
- |
- |
- |
- |
097 1件: 97 💬 |
948 |
Procedure: fmt |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
949 |
Procedure: gastroscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
950 |
Procedure: hyperbaric oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
097 1件: 97 💬 |
951 |
Procedure: infusion of saline |
- |
- |
- |
- |
097 1件: 97 💬 |
952 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 5件: 6 , 13, 19, 96, 97 💬 |
953 |
Procedure: narrow band imaging |
- |
- |
- |
- |
097 1件: 97 💬 |
954 |
Procedure: rectal dialysis |
- |
- |
- |
- |
097 1件: 97 💬 |
955 |
Procedure: rectosigmoidoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
956 |
Procedure: sham hyperbaric air |
- |
- |
- |
- |
097 1件: 97 💬 |
957 |
Procedure: sigmoidoscopy |
- |
- |
- |
- |
097 1件: 97 💬 |
958 |
Procedure: standardized fmt |
- |
- |
- |
- |
097 1件: 97 💬 |
959 |
Procedure: stool samples |
- |
- |
- |
- |
097 1件: 97 💬 |
960 |
Products containing aminosalicylate |
- |
- |
- |
- |
097 1件: 97 💬 |
961 |
Products containing azathioprine or 6-mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
097 1件: 97 💬 |
962 |
Proline |
Proline |
1件: D00035 D00035 💬 |
- |
- |
094 2件: 94, 97 💬 |
963 |
Promiten |
- |
- |
- |
- |
097 1件: 97 💬 |
964 |
Propionyl l-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
965 |
Propionyl l-carnitine hydrochloride |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
966 |
Propionyl-l-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
967 |
Propionylcarnitinhydrochlorid |
- |
- |
- |
- |
097 1件: 97 💬 |
968 |
Prv-300 |
- |
- |
- |
- |
097 1件: 97 💬 |
969 |
Ps |
- |
- |
- |
- |
046 3件: 46, 90, 97 💬 |
970 |
Ps-qd |
- |
- |
- |
- |
097 1件: 97 💬 |
971 |
Ps-sp |
- |
- |
- |
- |
097 1件: 97 💬 |
972 |
Psyllium |
Plantago seed |
1件: D05525 D05525 💬 |
- |
- |
097 1件: 97 💬 |
973 |
Psyllium husk |
Plantago seed |
1件: D05525 D05525 💬 |
- |
- |
097 1件: 97 💬 |
974 |
Psyllium husk powder |
Plantago seed |
1件: D05525 D05525 💬 |
- |
- |
097 1件: 97 💬 |
975 |
Ptg-100 |
- |
- |
- |
- |
097 1件: 97 💬 |
976 |
Pur 0110 |
- |
- |
- |
- |
097 1件: 97 💬 |
977 |
Pur 0110 rectal enema |
- |
- |
- |
- |
097 1件: 97 💬 |
978 |
Pur 0110 rectal enema 1000 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
979 |
Pur 0110 rectal enema 250 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
980 |
Pur 0110 rectal enema 500 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
981 |
Puri-nethol |
- |
- |
- |
- |
086 3件: 86, 96, 97 💬 |
982 |
Pv |
- |
- |
- |
- |
013 3件: 13, 97, 215 💬 |
983 |
Qbeco ssi |
- |
- |
- |
- |
097 1件: 97 💬 |
984 |
Raspberry |
Raspberry |
- |
- |
- |
097 1件: 97 💬 |
985 |
Ravagalimab |
- |
- |
- |
- |
053 2件: 53, 97 💬 |
986 |
Rdp58 |
- |
- |
- |
- |
097 1件: 97 💬 |
987 |
Rebamipide |
Rebamipide |
1件: D01121 D01121 💬 |
- |
- |
046 4件: 46, 53, 97, 271 💬 |
988 |
Recombinant factor xiii (rfxiii) |
Factor XIII (human) |
- |
- |
- |
097 2件: 97, 288 💬 |
989 |
Rectabul2mg rectal form |
- |
- |
- |
- |
097 1件: 97 💬 |
990 |
Rectal dialysis |
- |
- |
- |
- |
097 1件: 97 💬 |
991 |
Rectal tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
992 |
Regular treatment |
- |
- |
- |
- |
097 1件: 97 💬 |
993 |
Remestemcel-l |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
096 2件: 96, 97 💬 |
994 |
Remicade |
- |
- |
- |
- |
040 9件: 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
995 |
Remicade (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
996 |
Remicade 100 mg infuusiokuiva-aine, konsentraattiliuosta varten |
- |
- |
- |
- |
097 1件: 97 💬 |
997 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
998 |
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
999 |
Remsima |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
1000 |
Remsima (ct-p13) |
- |
- |
- |
- |
097 1件: 97 💬 |
1001 |
Remsima (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
1002 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
1003 |
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
1004 |
Remsima and inflectra |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1005 |
Retarded release phosphatidylcholine |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
1006 |
Retarded release phosphatidylcholine (rpc) |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
1007 |
Rhil-11 |
- |
- |
- |
- |
097 1件: 97 💬 |
1008 |
Rhumab beta7 |
- |
- |
- |
- |
097 1件: 97 💬 |
1009 |
Rhumab beta7, anti beta 7, pro145223 |
- |
- |
- |
- |
097 1件: 97 💬 |
1010 |
Rhumab beta7, anti beta7, pro145223 |
- |
- |
- |
- |
097 1件: 97 💬 |
1011 |
Riboflavin |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬 |
1012 |
Rifaximin |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
006 6件: 6 , 65, 96, 97, 99, 296 💬 |
1013 |
Risankizumab |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 96, 97, 271 💬 |
1014 |
Risankizumab (genetical recombination) |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
097 1件: 97 💬 |
1015 |
Risankizumab iv |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
1016 |
Risankizumab sc |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
1017 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
1018 |
Rivenprost |
Rivenprost |
- |
- |
- |
097 1件: 97 💬 |
1019 |
Rivenprost (drug) |
Rivenprost |
- |
- |
- |
097 1件: 97 💬 |
1020 |
Ro 549-0261/f04 |
- |
- |
- |
- |
097 1件: 97 💬 |
1021 |
Ro5490261 / f02 |
- |
- |
- |
- |
097 1件: 97 💬 |
1022 |
Ro5490261/f02 |
- |
- |
- |
- |
097 1件: 97 💬 |
1023 |
Ro5490261/f04-02 |
- |
- |
- |
- |
097 1件: 97 💬 |
1024 |
Ro7049665 |
- |
- |
- |
- |
097 1件: 97 💬 |
1025 |
Ro7246311 |
- |
- |
- |
- |
097 1件: 97 💬 |
1026 |
Rosiglitazone |
Rosiglitazone |
2件: D00596 D00596, D08491 D08491 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 5件: 46, 75, 97, 222, 265 💬 |
1027 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
1028 |
Rosuvastatin calcium |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 4件: 49, 79, 97, 299 💬 |
1029 |
Rosuvastatine eg |
- |
- |
- |
- |
097 1件: 97 💬 |
1030 |
Rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1031 |
Rtnv148b igg |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
1032 |
Salicylic acid |
Salicylic acid |
1件: D00097 D00097 💬 |
- |
- |
097 1件: 97 💬 |
1033 |
Saline |
- |
- |
- |
- |
006 10件: 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
1034 |
Salmon |
Salmon, unspecified |
- |
- |
- |
096 3件: 96, 97, 225 💬 |
1035 |
Salofalk |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1036 |
Salofalk 1000mg granu-stix |
- |
- |
- |
- |
097 1件: 97 💬 |
1037 |
Salofalk 1000mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
1038 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 1件: 97 💬 |
1039 |
Salofalk 4g/60ml klysma |
- |
- |
- |
- |
097 1件: 97 💬 |
1040 |
Salofalk granu-stix 500 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
1041 |
Salofalk® 1000mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
1042 |
Salofalk® 500 mg gastro-resistant tablet |
- |
- |
- |
- |
097 1件: 97 💬 |
1043 |
Salofalk® 500 mg tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
1044 |
Salofalk® 500mg |
- |
- |
- |
- |
097 1件: 97 💬 |
1045 |
Salofalk® 500mg granu-stix® |
- |
- |
- |
- |
097 1件: 97 💬 |
1046 |
Sandimmum |
- |
- |
- |
- |
097 1件: 97 💬 |
1047 |
Sandimmun |
- |
- |
- |
- |
097 2件: 97, 226 💬 |
1048 |
Sandimmun 50 mg/ml, infuusiokonsentraatti |
- |
- |
- |
- |
097 1件: 97 💬 |
1049 |
Sandimmun neoral |
- |
- |
- |
- |
060 3件: 60, 97, 226 💬 |
1050 |
Sandinum |
- |
- |
- |
- |
097 1件: 97 💬 |
1051 |
Sar339658 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
1052 |
Sb-656933 |
- |
- |
- |
- |
097 1件: 97 💬 |
1053 |
Sb-656933 tablets |
- |
- |
- |
- |
097 2件: 97, 299 💬 |
1054 |
Sb012 |
- |
- |
- |
- |
097 1件: 97 💬 |
1055 |
Sb5 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
1056 |
Sc12267 |
SC12267 |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
1057 |
Sc12267 (4sc-101) |
SC12267 |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
1058 |
Sch 900050 |
- |
- |
- |
- |
097 1件: 97 💬 |
1059 |
Semi-vegetarian diet |
- |
- |
- |
- |
097 1件: 97 💬 |
1060 |
Ser-287 |
- |
- |
- |
- |
097 1件: 97 💬 |
1061 |
Serum bovine immunoglobulin |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1062 |
Sf257 c59 |
- |
- |
- |
- |
097 1件: 97 💬 |
1063 |
Shingrix |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
1064 |
Shp647 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1065 |
Shr0302 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
1066 |
Simponi |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
1067 |
Simponi (golimumab) |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
1068 |
Simponi® |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
1069 |
Simponi® (golimumab) |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
1070 |
Simulect |
- |
- |
- |
- |
066 2件: 66, 97 💬 |
1071 |
Single dose-group a |
- |
- |
- |
- |
097 1件: 97 💬 |
1072 |
Smartject device delivery of golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
097 1件: 97 💬 |
1073 |
Smoking cigarettes |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1074 |
Smoking of cannabis |
Medical Cannabis |
- |
- |
- |
096 2件: 96, 97 💬 |
1075 |
Sodium hyaluronate |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
053 2件: 53, 97 💬 |
1076 |
Sodium picosulfate/magnesium citrate laxative |
Magnesium |
1件: D03265 D03265 💬 |
- |
- |
097 1件: 97 💬 |
1077 |
Solu-medrol |
- |
- |
- |
- |
013 7件: 13, 49, 50, 51, 53, 97, 211 💬 |
1078 |
Sotrastaurin |
Sotrastaurin |
1件: D09671 D09671 💬 |
PRKCD 4件: PRKCD, PRKCE, PRKCH, PRKCQ 💬 |
AGE-RAGE signaling pathway in diabetic complications 28件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
1079 |
Sotrastaurin (inn) acetate |
Acetate |
1件: D09671 D09671 💬 |
PRKCD 4件: PRKCD, PRKCE, PRKCH, PRKCQ 💬 |
AGE-RAGE signaling pathway in diabetic complications 28件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
097 1件: 97 💬 |
1080 |
Soybean |
Soybean |
- |
- |
- |
097 1件: 97 💬 |
1081 |
Soybean phosphatidylcholine |
Lecithin |
1件: D04682 D04682 💬 |
- |
- |
097 1件: 97 💬 |
1082 |
Spd476 |
- |
- |
- |
- |
097 1件: 97 💬 |
1083 |
Spd476 (mesalazine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
1084 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
1085 |
Spesolimab |
Spesolimab |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
1086 |
Spesolimab iv infusion |
Spesolimab |
- |
- |
- |
097 1件: 97 💬 |
1087 |
Spesolimab sc solution for injection |
Spesolimab |
- |
- |
- |
097 1件: 97 💬 |
1088 |
Sr140333b |
- |
- |
- |
- |
097 1件: 97 💬 |
1089 |
Srt2104 |
- |
- |
- |
- |
097 1件: 97 💬 |
1090 |
St 261 |
- |
- |
- |
- |
097 1件: 97 💬 |
1091 |
St-0529 |
- |
- |
- |
- |
097 1件: 97 💬 |
1092 |
St10-021 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1093 |
St261 |
- |
- |
- |
- |
097 1件: 97 💬 |
1094 |
Standard 2 hours-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1095 |
Standard therapy |
- |
- |
- |
- |
049 2件: 49, 97 💬 |
1096 |
Standardized anthocyanin-rich extract |
- |
- |
- |
- |
097 1件: 97 💬 |
1097 |
Standardized fodmap |
- |
- |
- |
- |
097 1件: 97 💬 |
1098 |
Stasis |
- |
- |
- |
- |
097 1件: 97 💬 |
1099 |
Stelara |
- |
- |
- |
- |
049 6件: 49, 56, 96, 97, 269, 271 💬 |
1100 |
Stelara® |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
1101 |
Sterile saline for injection |
- |
- |
- |
- |
097 1件: 97 💬 |
1102 |
Steroids |
- |
- |
- |
- |
046 7件: 46, 50, 51, 63, 66, 96, 97 💬 |
1103 |
Stnm01 |
- |
- |
- |
- |
097 1件: 97 💬 |
1104 |
Stnm01 1.84 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
1105 |
Stw5-ii |
- |
- |
- |
- |
097 1件: 97 💬 |
1106 |
Stw5-ii (iberogast n, bay98-7410) |
- |
- |
- |
- |
097 1件: 97 💬 |
1107 |
Sucrose |
Sucrose |
1件: D00025 D00025 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
1108 |
Sugar extract |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1109 |
Sulphsalazine, pentasa, asacol, colazide, depentum |
- |
- |
- |
- |
097 1件: 97 💬 |
1110 |
Suspension containing 7500 embryonated viable trichuris suis ova/15ml |
- |
- |
- |
- |
097 1件: 97 💬 |
1111 |
Suspension de microbiote fécal |
- |
- |
- |
- |
097 1件: 97 💬 |
1112 |
Synergy-1 |
- |
- |
- |
- |
097 1件: 97 💬 |
1113 |
Synergy1 |
- |
- |
- |
- |
097 1件: 97 💬 |
1114 |
Sübetaholzwurzel 1ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
1115 |
Süßholzwurzel 1ml/10ml |
- |
- |
- |
- |
097 1件: 97 💬 |
1116 |
Ta-650 |
- |
- |
- |
- |
037 4件: 37, 56, 96, 97 💬 |
1117 |
Ta-650 (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 97, 271 💬 |
1118 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1119 |
Tauroursoursodeoxycholic acid, brand name tudcabil |
- |
- |
- |
- |
097 1件: 97 💬 |
1120 |
Td-1473 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1121 |
Td-1473 dose a |
- |
- |
- |
- |
097 1件: 97 💬 |
1122 |
Td-1473 dose b |
- |
- |
- |
- |
097 1件: 97 💬 |
1123 |
Td-1473 dose c |
- |
- |
- |
- |
097 1件: 97 💬 |
1124 |
Td-3504 |
- |
- |
- |
- |
097 1件: 97 💬 |
1125 |
Telotristat |
Telotristat |
1件: D09973 D09973 💬 |
TPH1 2件: TPH1, TPH2 💬 |
Folate biosynthesis 4件: Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism |
097 1件: 97 💬 |
1126 |
Telotristat etiprate |
Telotristat |
1件: D09973 D09973 💬 |
TPH1 2件: TPH1, TPH2 💬 |
Folate biosynthesis 4件: Folate biosynthesis, Metabolic pathways, Serotonergic synapse, Tryptophan metabolism |
097 1件: 97 💬 |
1127 |
Terbinafine |
Terbinafine |
2件: D02219 D02219, D02375 D02375 💬 |
- |
- |
097 1件: 97 💬 |
1128 |
Tetomilast |
Tetomilast |
- |
- |
- |
096 2件: 96, 97 💬 |
1129 |
Tetracycline |
Tetracycline |
1件: D00201 D00201 💬 |
- |
- |
013 4件: 13, 46, 53, 97 💬 |
1130 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
1131 |
Thalidomide pharmion |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 3件: 85, 96, 97 💬 |
1132 |
Threonine |
Threonine |
1件: D00041 D00041 💬 |
- |
- |
086 3件: 86, 96, 97 💬 |
1133 |
Thrx-139060 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1134 |
Tj301 300mg |
- |
- |
- |
- |
097 1件: 97 💬 |
1135 |
Tj301 600mg |
- |
- |
- |
- |
097 1件: 97 💬 |
1136 |
To be confirmed |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
1137 |
To be requested |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1138 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
1139 |
Tofacitinib citrate |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 5件: 46, 49, 97, 107, 271 💬 |
1140 |
Tofacitinib citrate (clinical trial image) |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 2件: 46, 97 💬 |
1141 |
Tofacitinib citrate (phase iii formulation) |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 2件: 46, 97 💬 |
1142 |
Tofacitinib citrate (proposed commercial formulation - debossed) |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 2件: 46, 97 💬 |
1143 |
Tofacitinib citrate (proposed commercial formulation – debossed) |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 2件: 46, 97 💬 |
1144 |
Tofacitinib citrate (proposed commercialformulation - debossed) |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97 💬 |
1145 |
Top1288 |
- |
- |
- |
- |
097 1件: 97 💬 |
1146 |
Top1288 rectal solution |
- |
- |
- |
- |
097 1件: 97 💬 |
1147 |
Tp05 |
- |
- |
- |
- |
097 1件: 97 💬 |
1148 |
Tp05 coating a |
- |
- |
- |
- |
097 1件: 97 💬 |
1149 |
Tp05 coating b |
- |
- |
- |
- |
097 1件: 97 💬 |
1150 |
Tp05 coating d |
- |
- |
- |
- |
097 1件: 97 💬 |
1151 |
Tp05 coating e |
- |
- |
- |
- |
097 1件: 97 💬 |
1152 |
Tp05 coating h |
- |
- |
- |
- |
097 1件: 97 💬 |
1153 |
Traditional treatments |
- |
- |
- |
- |
097 1件: 97 💬 |
1154 |
Tralokinumab |
Tralokinumab |
1件: D09979 D09979 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 2件: 85, 97 💬 |
1155 |
Treatment algorithm a |
- |
- |
- |
- |
097 1件: 97 💬 |
1156 |
Treatment algorithm b |
- |
- |
- |
- |
097 1件: 97 💬 |
1157 |
Treatment algorithm c |
- |
- |
- |
- |
097 1件: 97 💬 |
1158 |
Tremfya |
- |
- |
- |
- |
037 2件: 37, 97 💬 |
1159 |
Tremfya® |
- |
- |
- |
- |
037 2件: 37, 97 💬 |
1160 |
Trexan |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
1161 |
Trexan inj 25 mg/ml |
- |
- |
- |
- |
097 1件: 97 💬 |
1162 |
Trichuris suis eggs |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1163 |
Trichuris suis ova |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97 💬 |
1164 |
Trichuris suis ova (tso) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1165 |
Tris |
Tromethamine |
1件: D00396 D00396 💬 |
- |
- |
096 2件: 96, 97 💬 |
1166 |
Tso |
- |
- |
- |
- |
013 3件: 13, 46, 97 💬 |
1167 |
Ucb4940 |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
1168 |
Ucmsc group |
- |
- |
- |
- |
097 1件: 97 💬 |
1169 |
Udca |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
067 5件: 67, 93, 94, 97, 296 💬 |
1170 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
013 5件: 13, 46, 57, 97, 113 💬 |
1171 |
Unknown |
- |
- |
- |
- |
067 2件: 67, 97 💬 |
1172 |
Upadacitinib |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 7件: 40, 41, 46, 49, 96, 97, 271 💬 |
1173 |
Upadacitinib (abt-494) |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97 💬 |
1174 |
Upadacitinib - direct compression-yellow |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97 💬 |
1175 |
Upadacitinib - wet granulation-yellow |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97 💬 |
1176 |
Upadacitinib -direct compression-yellow |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
097 1件: 97 💬 |
1177 |
Updacitinib (abt-494) |
- |
- |
- |
- |
097 1件: 97 💬 |
1178 |
Ur-12746-s |
- |
- |
- |
- |
097 1件: 97 💬 |
1179 |
Urbason |
- |
- |
- |
- |
013 3件: 13, 97, 222 💬 |
1180 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
006 8件: 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
1181 |
Ursodiol |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
008 6件: 8 , 20, 93, 97, 234, 299 💬 |
1182 |
Ursodiol (ursodeoxycholic acid, udca) |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
097 1件: 97 💬 |
1183 |
Ursofalk |
- |
- |
- |
- |
093 4件: 93, 94, 96, 97 💬 |
1184 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
1185 |
Ustekinumab dose based on bsa and body weight |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
097 1件: 97 💬 |
1186 |
Ustekinumab iv |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 2件: 49, 97 💬 |
1187 |
Ustekinumab iv infusion |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 2件: 96, 97 💬 |
1188 |
Ustekinumab sc |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 2件: 49, 97 💬 |
1189 |
Ustekinumab sc injection |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 2件: 96, 97 💬 |
1190 |
Usual current care |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1191 |
Uttr1147a |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1192 |
Uttr1147a, il22-fc, il-22fc |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1193 |
Uttr1147a/ro7021610 (active) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1194 |
V565 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1195 |
Vaccine vivotif + vaccine dukoral |
- |
- |
- |
- |
097 1件: 97 💬 |
1196 |
Vaccine vivotif + vaccine dukoral + oats |
Oat |
- |
- |
- |
097 1件: 97 💬 |
1197 |
Valganciclovir |
Valganciclovir |
1件: D02495 D02495 💬 |
- |
- |
028 6件: 28, 60, 85, 97, 299, 331 💬 |
1198 |
Vaminolac |
- |
- |
- |
- |
097 1件: 97 💬 |
1199 |
Vaminolac, komb. |
- |
- |
- |
- |
097 1件: 97 💬 |
1200 |
Vamorolone |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 2件: 97, 113 💬 |
1201 |
Vamorolone 4% suspension for oral dosing |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
1202 |
Vancomycin |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
046 7件: 46, 70, 94, 96, 97, 296, 299 💬 |
1203 |
Vancomycin pre-treat |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
097 1件: 97 💬 |
1204 |
Vancomycin pre-treatment |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
097 1件: 97 💬 |
1205 |
Vatelizumab |
Vatelizumab |
- |
- |
- |
013 2件: 13, 97 💬 |
1206 |
Vb-201 |
VB-201 |
- |
- |
- |
097 1件: 97 💬 |
1207 |
Vb-201 160mg |
VB-201 |
- |
- |
- |
097 1件: 97 💬 |
1208 |
Vedolizumab |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 3件: 94, 96, 97 💬 |
1209 |
Vedolizumab 108 mg sc |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1210 |
Vedolizumab 300 mg |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1211 |
Vedolizumab 300 mg iv |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1212 |
Vedolizumab injection |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1213 |
Vedolizumab intravenous (iv), vedolizumab subcutaneous (sc), placebo iv |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1214 |
Vedolizumab intravenous injection |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1215 |
Vedolizumab iv |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 3件: 94, 96, 97 💬 |
1216 |
Vedolizumab iv, placebo iv, placebo sc |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1217 |
Vedolizumab iv, placebo sc |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
097 1件: 97 💬 |
1218 |
Vedolizumab sc |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1219 |
Vedolizumab sc 108 mg |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1220 |
Vedolizumab subcutaneous injection |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1221 |
Vidofludimus |
Vidofludimus |
- |
- |
- |
013 5件: 13, 46, 94, 96, 97 💬 |
1222 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 4件: 13, 94, 96, 97 💬 |
1223 |
Vidofludimus calcium dihydrate |
Calcium |
- |
- |
- |
097 1件: 97 💬 |
1224 |
Vigantol |
- |
- |
- |
- |
013 4件: 13, 65, 96, 97 💬 |
1225 |
Vigantol oel |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1226 |
Vigantol oel tm |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1227 |
Visilizumab |
Visilizumab |
1件: D06314 D06314 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
1228 |
Visilizumab (hum291 |
Visilizumab |
1件: D06314 D06314 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
097 1件: 97 💬 |
1229 |
Visilizumab (nuvion) |
Visilizumab |
1件: D06314 D06314 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
097 1件: 97 💬 |
1230 |
Visilizumab (nuvion® |
Visilizumab |
1件: D06314 D06314 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
097 1件: 97 💬 |
1231 |
Vitamin b2 |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
097 1件: 97 💬 |
1232 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
1233 |
Vitamin d drops |
Vitamin D |
- |
- |
- |
096 2件: 96, 97 💬 |
1234 |
Vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 11件: 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1235 |
Vitamin e |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
002 11件: 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1236 |
Vitamin e 800iu |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
096 2件: 96, 97 💬 |
1237 |
Vitamin k |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 5件: 13, 46, 96, 97, 299 💬 |
1238 |
Vitamin k 10 mg |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
096 2件: 96, 97 💬 |
1239 |
Vivotif |
- |
- |
- |
- |
097 1件: 97 💬 |
1240 |
Vsl#3 |
- |
- |
- |
- |
096 3件: 96, 97, 291 💬 |
1241 |
Vsl#3 (original de simone formulation) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1242 |
Vsl#3® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1243 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1244 |
Warfarin 10 mg |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 2件: 96, 97 💬 |
1245 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1246 |
Wharton jelly mesenchymal stem cells |
- |
- |
- |
- |
097 1件: 97 💬 |
1247 |
Xeljanz |
- |
- |
- |
- |
046 3件: 46, 97, 271 💬 |
1248 |
Xeljanz 5 mg film-coated tablets |
- |
- |
- |
- |
046 2件: 46, 97 💬 |
1249 |
Xeljanz 5mg film-coated tablets |
- |
- |
- |
- |
097 1件: 97 💬 |
1250 |
Z-206 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1251 |
Zessly |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1252 |
Zoenasa-1:4 |
- |
- |
- |
- |
097 1件: 97 💬 |